Why is Fredun Pharma falling/rising?

As of 17-Sep, Fredun Pharmaceuticals Ltd is experiencing a price increase, currently at 1,255.00, reflecting a rise of 5.0 (0.4%). The stock has shown strong performance recently, gaining 3.38% over the last three days and outperforming its sector by 0.36% today. It reached an intraday high of Rs 1,290, although it also saw a low of Rs 1,220 during the day. The stock is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a positive trend. Additionally, there has been a notable increase in investor participation, with delivery volume rising by 33.92% compared to the 5-day average. Unfortunately, the Positive and Negative Factors section is unavailable, which limits further insights into specific catalysts for the stock's movement.
Broader market context shows that while Fredun Pharmaceuticals has outperformed the benchmark Sensex in the short term, with a 1-week return of +0.80% compared to the Sensex's +1.56%, its longer-term performance remains mixed. Over the past month, the stock has increased by 19.85%, significantly outpacing the Sensex's 2.60% gain. Year-to-date, Fredun Pharmaceuticals has achieved a remarkable return of 70.23%, while the Sensex has only risen by 5.83%. This strong relative performance suggests that investor sentiment towards Fredun Pharmaceuticals remains positive, contributing to its rising stock price.